Schrödinger, Inc. logo

Schrödinger, Inc. (SDGR)

Market Closed
3 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
20. 71
-0.17
-0.8142%
$
1.47B Market Cap
- P/E Ratio
- Div Yield
771,476 Volume
- Eps
$ 20.88
Previous Close
Add Transaction
Day Range
20.25 21.29
Year Range
10.95 23.02
Want to track SDGR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago
Schrodinger Q2 Earnings Call Highlights

Schrodinger Q2 Earnings Call Highlights

Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broadened across large pharmaceutical customers, biotechnology companies and materials-science customers, while the company launched early access for Bunsen, its agentic AI co-scientist.

Marketbeat | 4 weeks ago
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.6 per share. This compares to a loss of $0.59 per share a year ago.

Zacks | 4 weeks ago
Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Schrödinger is challenging the incumbent drug-trial method—physics-simulated molecular design that cuts the cost, time, and animal testing of building and screening thousands of candidates. The current EV is roughly accounted for by the software leg alone - the royalties business and the disruption TAM are barely priced in, if at all. Three drivers - a regulatory push away from animal testing, AI-led consumption growth, and Bunsen - open up asymmetric upside that is not required for the base case.

Seekingalpha | 1 month ago
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 3 months ago
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 months ago
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.

Zacks | 4 months ago
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors

Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors

On April 22, 2026, Schrodinger Inc (SDGR) shares fell 4.1% today, bringing the current price to $12.35. The stock has experienced a 52-week range between $10.95

Gurufocus | 4 months ago
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Seekingalpha | 5 months ago
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seekingalpha | 6 months ago
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago
Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade

Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade

The consensus price target hints at a 46.2% upside potential for Schrodinger (SDGR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks | 8 months ago
Loading...
Load More